{"id":844,"date":"2026-10-20T12:12:54","date_gmt":"2026-10-20T01:12:54","guid":{"rendered":"http:\/\/novameds.local\/au\/?post_type=product&#038;p=844"},"modified":"2026-10-20T12:59:06","modified_gmt":"2026-10-20T01:59:06","slug":"catalog-tb-500-fragment-17-23","status":"publish","type":"product","link":"https:\/\/novameds.health\/au\/product\/catalog-tb-500-fragment-17-23\/","title":{"rendered":"TB-500 Fragment (17-23)"},"content":{"rendered":"<section id=\"composition\" data-nav=\"Composition and product details\">\n<h2>Composition and product details<\/h2>\n<div class=\"nm-catalog-document\">\n<div>\n<h2>Overview<\/h2>\n<div>\n<p>TB-500 Fragment (17-23) is a synthetic research peptide consisting of the key active amino acid sequence from the actin-binding region of thymosin beta-4. Supplied as a high-purity lyophilized powder, it\u2019s used in laboratory research to study cellular migration, actin dynamics, angiogenic signaling, and tissue remodeling processes.<\/p>\n<ul>\n<li> <span><b>High Purity<\/b> \u2013 99% Purity Guaranteed<\/span><\/li>\n<li> Independently Lab Tested<\/li>\n<li> Research Grade Quality<\/li>\n<li> For Laboratory Research Use Only<\/li>\n<\/ul><\/div>\n<div>\n<div><span>All SwissChems products are independently third-party tested at a USA-based HPLC-licensed laboratory prior to distribution. Certificates of Analysis (COA) are published on the Independent Test Results page and available at product level. If any independently conducted HPLC test returns a negative result, SwissChems will refund: (1) the cost of the HPLC test, and (2) the full order amount including shipping.<\/span><\/div>\n<div>\n<div><span>TB-500 Fragment (17-23)<\/span><span>5mg 1vial | 10mg 1vial<\/span><\/div>\n<\/div><\/div>\n<\/p><\/div>\n<div>\n<h2>Properties<\/h2>\n<div class=\"nm-catalog-table\" tabindex=\"0\" role=\"region\" aria-label=\"Product data\">\n<table>\n<tbody>\n<tr>\n<th>Chemical Formula<\/th>\n<td>C38H68N10O14<\/td>\n<\/tr>\n<tr>\n<th>Synonyms<\/th>\n<td>TB-500 Fragment (17-23), Thymosin Beta-4 Fragment 17-23, LKKTETQ<\/td>\n<\/tr>\n<tr>\n<th>Molar Mass<\/th>\n<td>889.02 g\/mol<\/td>\n<\/tr>\n<tr>\n<th>CAS Number<\/th>\n<td>885340-08-9<\/td>\n<\/tr>\n<tr>\n<th>PubChem CID<\/th>\n<td>62707662<\/td>\n<\/tr>\n<tr>\n<th>Available formats<\/th>\n<td>5mg 1vial \u00b7 10mg 1vial<\/td>\n<\/tr>\n<tr>\n<th>Shelf Life<\/th>\n<td>36 months<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div><\/div>\n<div>\n<h2>Research<\/h2>\n<p>TB-500 Fragment (17-23) is the N-acetylated seven-residue sequence (Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln) corresponding to the LKKTET actin-binding motif found at position 17\u201323 of Thymosin Beta-4. Because this short sequence contains the core determinant of T\u03b24&#8217;s interaction with G-actin, it is frequently used in comparative studies examining whether a given cytoskeletal or signaling effect requires the full 43-residue protein or can be reproduced by the isolated binding motif alone.<\/p>\n<p>Experimental work involving this fragment has focused on actin monomer sequestration assays, structure-activity mapping of the T\u03b24 actin-binding domain, and mechanistic comparisons between the minimal fragment and full-length T\u03b24 in cytoskeletal reorganization models. Because of its small size relative to full-length T\u03b24, the fragment is also used in analytical chemistry and mass-spectrometry method development, including doping-control and peptide-identification research.<\/p>\n<\/p><\/div>\n<div>\n<h2>FAQ<\/h2>\n<div>\n<details>\n<summary>\n\t\t\t\t\t\t\t\t\t\t<span>How does TB-500 Fragment (17-23) differ from full-length TB-500\/Thymosin Beta-4?<\/span><\/p>\n<\/summary>\n<div>\n<p>The Fragment (17-23) contains only the seven-residue LKKTET actin-binding motif that sits within the larger 43-residue T\u03b24 sequence, rather than the full protein. It is typically used to test whether an observed effect of full-length T\u03b24 depends on the whole protein or can be attributed to this minimal actin-binding region alone.<\/p>\n<\/div>\n<\/details>\n<details>\n<summary>\n\t\t\t\t\t\t\t\t\t\t<span>What is the primary research application of this fragment?<\/span><\/p>\n<\/summary>\n<div>\n<p>It&#8217;s used mainly in comparative actin-binding and structure-function studies, where researchers assess G-actin interaction and cytoskeletal effects of the isolated motif relative to full-length Thymosin Beta-4. It also sees use in analytical\/mass-spectrometry method development for peptide identification.<\/p>\n<\/div>\n<\/details>\n<details>\n<summary>\n\t\t\t\t\t\t\t\t\t\t<span>Is this compound identical to commercial &#8220;TB-500&#8221;?<\/span><\/p>\n<\/summary>\n<div>\n<p>The name &#8220;TB-500&#8221; has been used inconsistently across the peptide supply industry \u2014 some vendors apply it to the full 43-residue T\u03b24 analogue, while analytical and anti-doping literature identifies &#8220;TB-500&#8221; specifically as this Ac-LKKTETQ fragment. This listing is the isolated 7-residue fragment (CAS 885340-08-9); check formula and CAS number against any other &#8220;TB-500&#8221; product before comparing them directly.<\/p>\n<\/div>\n<\/details><\/div>\n<\/p><\/div>\n<\/div>\n<\/section>\n","protected":false},"excerpt":{"rendered":"<p>TB-500 Fragment (17-23) is a synthetic research peptide consisting of the key active amino acid sequence from the actin-binding region of thymosin beta-4.<\/p>\n<p>Presentation: TB-500 Fragment (17-23).<\/p>\n<p>Select the required strength and pack size.<\/p>\n<p class=\"nm-research-disclaimer\">For laboratory research only. Not for human or veterinary use.<\/p>\n<p class=\"nm-catalog-image-note\"><small>Illustrative packaging generated with AI.<\/small><\/p>\n","protected":false},"featured_media":992,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[26],"product_tag":[],"nm_classification":[],"class_list":["post-844","product","type-product","status-publish","has-post-thumbnail","product_cat-recovery-regeneration","first","instock","shipping-taxable","product-type-variable","has-default-attributes"],"_links":{"self":[{"href":"https:\/\/novameds.health\/au\/wp-json\/wp\/v2\/product\/844","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/novameds.health\/au\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/novameds.health\/au\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/novameds.health\/au\/wp-json\/wp\/v2\/comments?post=844"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/novameds.health\/au\/wp-json\/wp\/v2\/media\/992"}],"wp:attachment":[{"href":"https:\/\/novameds.health\/au\/wp-json\/wp\/v2\/media?parent=844"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/novameds.health\/au\/wp-json\/wp\/v2\/product_brand?post=844"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/novameds.health\/au\/wp-json\/wp\/v2\/product_cat?post=844"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/novameds.health\/au\/wp-json\/wp\/v2\/product_tag?post=844"},{"taxonomy":"nm_classification","embeddable":true,"href":"https:\/\/novameds.health\/au\/wp-json\/wp\/v2\/nm_classification?post=844"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}